J. Bowen-Morris

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants.

J. Deeks, S. Lockhart, M. English, 2000, Vaccine.

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T

D. Crook, E. Moxon, D. Griffiths, 1997, Archives of disease in childhood.

Hib vaccination in infants born prematurely

J. McVernon, E. Moxon, R. Booy, 2003, Archives of disease in childhood.

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.

J. McVernon, A. Pollard, E. Moxon, 2005, JAMA.

A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.

J. McVernon, A. Pollard, E. Moxon, 2007, Vaccine.

Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.

J. Deeks, E. Moxon, R. Booy, 2000, JAMA.

Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol

J. Gregory, A. Marwaha, T. Tree, 2021, BMJ Open.

Immunogenicity and Immunologic Memory of Meningococcal C Conjugate Vaccine in Premature Infants

A. Pollard, E. Moxon, R. Borrow, 2005, The Pediatric infectious disease journal.